BeiGene Says Israeli Ministry Of Health Approved TEVIMBRA (Tislelizumab) As Monotherapy For Treatment Of Adult Patients With Unresectable Or Metastatic OESCC After Prior Systemic Chemotherapy
Exelixis Unveils Additional Data on Cabometyx for Neuroendocrine Tumors
Cantor Fitzgerald Reiterates Neutral on Gilead Sciences, Maintains $70 Price Target
Gilead Sciences Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Alkermes, Maintains $48 Price Target
Alkermes Analyst Ratings
DeSantis Administration Cautions Against Pfizer, Moderna MRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions
BioNTech Shares Are Trading Higher B of A Securities and JP Morgan Raised Their Respective Price Targets on the Stock.
Exas Science Shares Are Trading Higher After the Company Announced Data for Its Blood-based Colorectal Cancer Screening Test.
HC Wainwright & Co. Reiterates Buy on BioNTech, Maintains $113 Price Target
Chewy, Broadcom And MicroStrategy Are Among Top 10 Large Cap Stock Gainers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio?
Forecasting The Future: 8 Analyst Projections For BioNTech
Summit Boosts Instil, BioNTech as Lead Drug Beats Merck's Keytruda
(HALO) - Analyzing Halozyme Therapeutics's Short Interest
Canaccord Genuity Maintains Buy on Exact Sciences, Maintains $75 Price Target
BioNTech Analyst Ratings
"Florida Discourages Use Of MRNA Covid Vaccines In Older Adults; In Updated Guidance To Health Care Providers, Florida Health Officials Advise That "Non-mRNA Covid-19 Vaccines And Treatment" Should Be Prioritized" - NBC News
$100 Invested In This Stock 20 Years Ago Would Be Worth $900 Today
Market Whales and Their Recent Bets on BNTX Options
Novavax COVID-19 Vaccines Now Available